{
  "slug": "AIM-24-11-2022-canabis-2022",
  "bundle_path": "backups/all_bundles/code/AIM-24-11-2022-canabis-2022.json",
  "document_id": "cb00a546-fc20-4839-b359-1040ceabb1b8",
  "document_title": "AIM.24.11.2022 canabis",
  "tree_json": {
    "doc_name": "AIM-24-11-2022-canabis-2022",
    "doc_description": "This document is the Democratic Republic of the Congo's ministerial decree (Arrêté) dated November 24, 2022, which establishes the comprehensive legal framework for regulating the cultivation, production, and use of cannabis and other narcotics exclusively for medical and scientific purposes.",
    "structure": [
      {
        "title": "AIM.24.11.2022 canabis",
        "node_id": "0000",
        "prefix_summary": "# AIM.24.11.2022 canabis",
        "line_num": 1,
        "nodes": [
          {
            "title": "Article 1",
            "node_id": "0001",
            "summary": "###### Article 1\n\nLe pr�sent Arr�t� a pour\nobjet de fixer les conditions d'exploitation des stup�fiants et des\nsubstances psychotropes � des fins m�dicales et scientifiques.",
            "line_num": 4
          },
          {
            "title": "Article 10",
            "node_id": "0002",
            "summary": "###### Article 10\n\nLa production r�pond aux exigences\nd'assurance qualit� et de bonnes pratiques.",
            "line_num": 11
          },
          {
            "title": "Article 100",
            "node_id": "0003",
            "summary": "###### Article 100\n\nLes vari�t�s de cannabis\nautoris�es, pour la culture � des fins m�dicales, sont celles dont les teneurs\nsont respectivement inf�rieures ou �gales � 0,2 % d�Acide delta\nT�trahydrocannabinol (THC), et �lev�e en Cannabidiol (CBD).\nPour le cannabis � des fins\nscientifiques, il n�y a pas de limite en teneur THC.",
            "line_num": 17
          },
          {
            "title": "Article 101",
            "node_id": "0004",
            "summary": "###### Article 101\n\nLa culture de la plante de\ncannabis est de type industriel en R�publique D�mocratique du Congo.\nToute exploitation agricole\nnon industrielle de cette plante est soumise � une d�rogation pr�alable du\nMinistre ayant la Sant� dans ses attributions, apr�s avis de la Commission\nMultisectorielle Permanente.",
            "line_num": 27
          },
          {
            "title": "Section 3 : De la production",
            "node_id": "0005",
            "prefix_summary": "##### Section 3 : De la production",
            "line_num": 37,
            "nodes": [
              {
                "title": "Article 102",
                "node_id": "0006",
                "summary": "###### Article 102\n\nLa superficie sur laquelle la\nplante de cannabis est cultiv�e est clairement d�limit�e par un agronome de\nbrigade. Toute augmentation de cette superficie fait l'objet d'une autorisation\npr�alable du Ministre ayant la Sant� dans ses attributions, apr�s avis de la\nCommission Multisectorielle Permanente.\nL�exploitation industrielle\nne peut �tre inf�rieure � cinq (5) hectares.\nL�exploitation familiale ne\npeut exc�der un (1) hectare.\nL�exploitation de type\nfamilial commence � partir d�un (1) hectare et ne peut exc�der cinq (5)\nhectares.\n\ndu cannabis",
                "line_num": 40
              },
              {
                "title": "Article 103",
                "node_id": "0007",
                "summary": "###### Article 103\n\nEst producteur du cannabis\naux termes de l'article 2, toute personne morale de droit congolais qui remplit\nles conditions pr�vues par le pr�sent Arr�t�.",
                "line_num": 58
              },
              {
                "title": "Article 104",
                "node_id": "0008",
                "summary": "###### Article 104\n\nLa production du cannabis\ndoit r�pondre aux exigences d'assurance qualit� et de bonnes pratiques y\nrelatives en vigueur en R�publique D�mocratique du Congo.",
                "line_num": 65
              }
            ]
          },
          {
            "title": "Section 4 : De l�octroi, de",
            "node_id": "0009",
            "prefix_summary": "##### Section 4 : De l�octroi, de",
            "line_num": 72,
            "nodes": [
              {
                "title": "Article 105",
                "node_id": "0010",
                "summary": "###### Article 105\n\nL'autorisation de production\ndu cannabis est accord�e par le Ministre ayant la Sant� dans ses attributions,\napr�s avis de la Commission Multisectorielle Permanente.\n\nla suspension et du retrait des autorisations de culture de la plante de\ncannabis et de production du cannabis",
                "line_num": 75
              },
              {
                "title": "Article 106",
                "node_id": "0011",
                "summary": "###### Article 106\n\nLes autorisations de culture\nde la plante de cannabis et de production du cannabis, telles que stipul�es aux\narticles 7 et 14 du pr�sent Arr�t�, sont accord�es moyennant paiement des taxes\ndont les taux et les modalit�s sont fix�s par un Arr�t� interminist�riel des\nMinistres ayant la Sant� et les Finances dans leurs attributions respectives.",
                "line_num": 85
              },
              {
                "title": "Article 107",
                "node_id": "0012",
                "summary": "###### Article 107\n\nL�autorisation de culture\nindustrielle est octroy�e � la personne morale requ�rante qui justifie d�une\ncapacit� technique et financi�re de production industrielle.",
                "line_num": 94
              },
              {
                "title": "Article 108",
                "node_id": "0013",
                "summary": "This partial document outlines the application process for obtaining authorization to cultivate cannabis plants and produce cannabis for medical and scientific purposes. It specifies that applications must be submitted to the Minister of Health and copies sent to designated bodies. It details the required documentation for a complete application file, including 16 specific items ranging from company identification to security measures. Finally, it states that the Permanent Multisectorial Commission is responsible for processing applications and providing technical advice to the Minister of Health via ACOREP.",
                "line_num": 101
              },
              {
                "title": "Article 109",
                "node_id": "0014",
                "summary": "###### Article 109\n\nLe dossier de demande est\nconstitu�, conform�ment aux dispositions de l�Article 21 du pr�sent Arr�t�.\nLa lettre de demande est\naccompagn�e du dossier complet.",
                "line_num": 149
              },
              {
                "title": "Article 11",
                "node_id": "0015",
                "summary": "This partial document specifies record-keeping and labeling requirements for pharmaceutical manufacturers and pharmacists who use narcotics in their operations. It mandates a special manufacturing register to track quantities, dates, and metabolite content of raw materials and finished products, as well as any losses. It also requires that specific preparations be stored in identifiable, marked containers.",
                "line_num": 157
              }
            ]
          },
          {
            "title": "Section 5 : De la d�tention,",
            "node_id": "0016",
            "prefix_summary": "##### Section 5 : De la d�tention,",
            "line_num": 176,
            "nodes": [
              {
                "title": "Article 110",
                "node_id": "0017",
                "summary": "###### Article 110\n\nL�Autorit� Congolaise de\nR�glementation Pharmaceutique peut inviter le requ�rant � fournir des\ninformations compl�mentaires sur le dossier introduit par lui, devant la\nCommission Multisectorielle Permanente.\n\nde la production et de la commercialisation de la plante de cannabis, du\ncannabis et des produits du cannabis",
                "line_num": 179
              },
              {
                "title": "Article 111",
                "node_id": "0018",
                "summary": "###### Article 111\n\nLa d�tention, la production\net la commercialisation de la plante de cannabis, du cannabis et des produits du\ncannabis � des fins m�dicales et scientifiques sont soumises aux dispositions\n�dict�es par le pr�sent Arr�t�.",
                "line_num": 190
              },
              {
                "title": "Article 112",
                "node_id": "0019",
                "summary": "###### Article 112\n\nL�importation des semences de\ncannabis est interdite en R�publique D�mocratique du Congo � condition d�en\navoir obtenu l�autorisation aupr�s de l�ACOREP, apr�s avis de la Commission\nMultisectorielle Permanente.\nDe m�me, l�importation des\nplantes de cannabis et du cannabis, pour de besoin commercial, est proscrite.\nL�importation des produits\nfinis du cannabis aux fins m�dicales est interdite en R�publique D�mocratique du\nCongo, � condition d�en avoir obtenu l�autorisation expresse aupr�s de l�ACOREP,\napr�s avis de la Commission Multisectorielle Permanente.",
                "line_num": 198
              }
            ]
          },
          {
            "title": "Section 6 : Du transport et",
            "node_id": "0020",
            "prefix_summary": "##### Section 6 : Du transport et",
            "line_num": 212,
            "nodes": [
              {
                "title": "Article 113",
                "node_id": "0021",
                "summary": "###### Article 113\n\nL�exportation du cannabis �\nl��tat brut est strictement interdite.\nSeuls les produits semi-finis\net finis � base du cannabis sont autoris�s � l�exportation sur l�autorisation de\nl�ACOREP, apr�s avis de la Commission Multisectorielle Permanente.\n\ndu convoyage de la plante de cannabis, du cannabis et des produits du cannabis",
                "line_num": 215
              },
              {
                "title": "Article 114",
                "node_id": "0022",
                "summary": "###### Article 114\n\nL�autorisation de transport\net de convoyage locaux de la plante de cannabis, du cannabis et des produits du\ncannabis est octroy�e par l�ACOREP apr�s avis technique de la Commission\nMultisectorielle Permanente sur base de demandes �crites, distinctes pour\nchacune de ces deux op�rations.\nLa Commission\nMultisectorielle Permanente participe � ces op�rations et accompagne les colis\njusqu�� la porte de sortie lorsqu�il s�agit uniquement de l�op�ration\nd�exportation des produits semi-finis et finis � base du cannabis.",
                "line_num": 226
              }
            ]
          },
          {
            "title": "Section 7 : De la",
            "node_id": "0023",
            "prefix_summary": "##### Section 7 : De la",
            "line_num": 239,
            "nodes": [
              {
                "title": "Article 115",
                "node_id": "0024",
                "summary": "###### Article 115\n\nLe transport et le convoyage\nlocaux de la plante de cannabis, du cannabis et des produits du cannabis se font\npar des moyens s�curis�s et discrets en fonction des risques y associ�s.\nDans certains cas, le\ntransport et le convoyage locaux des colis peuvent �tre externalis�s aux\nfournisseurs de services de transport s�curis�s agr��s. Le d�tenteur de la\nlicence en est responsable en vertu de ces dispositions.\n\nsurveillance, de l'inspection et du contr�le du cannabis",
                "line_num": 242
              },
              {
                "title": "Article 116",
                "node_id": "0025",
                "summary": "###### Article 116\n\nLe suivi de gestion des\ncannabis et produits d�riv�s est assur� au quotidien par la Commission\nMultisectorielle Permanente � travers le territoire national.",
                "line_num": 255
              },
              {
                "title": "Article 117",
                "node_id": "0026",
                "summary": "This partial document outlines the powers and procedures for the inspection and control of cannabis-related activities. It specifies that inspectors, accompanied by police and other services, enable a Permanent Multisectoral Commission to monitor operations to ensure compliance with the relevant decree. It further states that an inspector can, during a control mission, order any authorized person to provide any information, documents, and/or samples required for the inspection, as specified by the inspector.",
                "line_num": 262
              }
            ]
          },
          {
            "title": "Section 8 : Des Sanctions",
            "node_id": "0027",
            "prefix_summary": "##### Section 8 : Des Sanctions",
            "line_num": 279,
            "nodes": [
              {
                "title": "Article 118",
                "node_id": "0028",
                "summary": "###### Article 118\n\nLes exploitants agricoles, les producteurs industriels, les �tablissements de\nvente en gros, les officines pharmaceutiques, les laboratoires pharmaceutiques,\nles laboratoires de contr�le qualit� et de recherche, qui manipulent les\ncannabis et les produits d�riv�s, sont tenus de se soumettre au contr�le de la\nCommission Multisectorielle Permanente.",
                "line_num": 282
              },
              {
                "title": "Article 119",
                "node_id": "0029",
                "summary": "This partial document outlines the grounds and procedure for the revocation of a cannabis sector operator's license or authorization. It lists specific violations that can lead to revocation, including breaches of regulations, unauthorized changes to activities, illicit trafficking, diversion to non-medical/non-scientific use, and failure to comply with oversight. It concludes by stating that the final revocation decision is made by the Minister of Health, following advice from a Permanent Multisectorial Commission.",
                "line_num": 291
              },
              {
                "title": "Article 12",
                "node_id": "0030",
                "summary": "###### Article 12\n\nLa production des stup�fiants et des\nsubstances psychotropes est exclusivement de type industriel pharmaceutique.\nToute production non industrielle\npharmaceutique des stup�fiants et des substances psychotropes est\nstrictement interdite, � condition d�en avoir l�autorisation de l�autorit�\ncomp�tente.",
                "line_num": 311
              },
              {
                "title": "Article 120",
                "node_id": "0031",
                "summary": "###### Article 120\n\nEn cas de manquements aux dispositions du pr�sent Arr�t�, le Ministre ayant la\nSant� dans ses attributions peut, apr�s avis de la Commission Multisectorielle\nPermanente, mettre en place des mesures correctives dans un d�lai ne d�passant\npas trente (30) jours.\nA l��ch�ance de ce d�lai, le Ministre peut, selon le r�sultat de la mise en\noeuvre des mesures correctives, soit maintenir les licences ou les\nautorisations, soit les retirer conform�ment au pr�sent Arr�t�.\nChapitres IX : Des dispositions p�nales",
                "line_num": 321
              }
            ]
          },
          {
            "title": "Chapitre X : Des dispositions finales",
            "node_id": "0032",
            "prefix_summary": "#### Chapitre X : Des dispositions finales",
            "line_num": 333,
            "nodes": [
              {
                "title": "Article 121",
                "node_id": "0033",
                "summary": "###### Article 121\n\nSans pr�judice des dispositions du Code p�nal congolais livre II, les\ninfractions aux dispositions du pr�sent Arr�t� seront punies des peines pr�vues\npar l'Ordonnance n� 27bis/Hyg. du 15 mars 1933 sur l�exercice de la pharmacie en\nson article 64, et la Loi n�18/035 du 13 d�cembre 2018 fixant les principes\nfondamentaux relatifs � l'organisation de la Sant�.",
                "line_num": 336
              },
              {
                "title": "Article 122",
                "node_id": "0034",
                "summary": "###### Article 122\n\nSont abrog�es, toutes les dispositions ant�rieures contraires au pr�sent Arr�t�.",
                "line_num": 345
              },
              {
                "title": "Article 123",
                "node_id": "0035",
                "summary": "###### Article 123\n\nLe Secr�taire g�n�ral � la Sant� Publique, Hygi�ne et Pr�vention est charg� de\nl'ex�cution du pr�sent Arr�t� qui entre en vigueur � la date de sa signature.\nFait � Kinshasa, le 24 novembre 2022.\nCe\nsite est en construction - pour toutes informations; remarques\n[adressez\nnous un courriel]Les textes ne font\nque refl�ter les textes en possession des associations qui\nn'engagent pas leur responsabilit�.",
                "line_num": 350
              },
              {
                "title": "Article 13",
                "node_id": "0036",
                "summary": "###### Article 13\n\nL'autorisation de production des stup�fiants\net des substances psychotropes est accord�e par le Ministre ayant la Sant�\ndans ses attributions.",
                "line_num": 363
              },
              {
                "title": "Article 14",
                "node_id": "0037",
                "summary": "###### Article 14\n\nL'autorisation de production vis�e �\nl'article 13 pr�c�dent �num�re limitativement les stup�fiants et les\nsubstances psychotropes concern�s.",
                "line_num": 370
              },
              {
                "title": "Article 15",
                "node_id": "0038",
                "summary": "###### Article 15\n\nLe Ministre ayant la Sant� dans ses\nattributions v�rifie si les concessions sur lesquelles la production est\nfaite sont obtenues conform�ment � la l�gislation en vigueur.",
                "line_num": 377
              },
              {
                "title": "Article 16",
                "node_id": "0039",
                "summary": "###### Article 16\n\nLes conditions d'octroi des autorisations de\nculture et de production sont reprises dans le manuel de gouvernance.",
                "line_num": 384
              }
            ]
          },
          {
            "title": "Chapitre III : De l'octroi, de la suspension",
            "node_id": "0040",
            "prefix_summary": "#### Chapitre III : De l'octroi, de la suspension",
            "line_num": 390,
            "nodes": [
              {
                "title": "Article 17",
                "node_id": "0041",
                "summary": "###### Article 17\n\nLes autorisations vis�es aux articles 7 et\n14 du pr�sent Arr�t� sont accord�es moyennant paiement des taxes dont les\ntaux et les modalit�s sont fix�s par un Arr�t� interminist�riel des\nMinistres ayant la Sant� et les Finances dans leurs attributions.\n\net du retrait des autorisations de culture et de production des stup�fiants\net des substances psychotropes\nSection 1 : De l�octroi de l�autorisation de\nculture et de production des stup�fiants et des substances psychotropes",
                "line_num": 393
              },
              {
                "title": "Article 18",
                "node_id": "0042",
                "summary": "###### Article 18\n\nLa demande tendant � l�obtention\nd'autorisation de culture des stup�fiants et des substances psychotropes\npeut �tre introduite par les personnes physiques ou par les soci�t�s\ncommerciales.\nToutefois, en ce qui concerne la demande\nrelative � la production de ces stup�fiants et substances psychotropes, elle\nne peut �tre introduite que par les soci�t�s commerciales oeuvrant dans le\ndomaine pharmaceutique en R�publique D�mocratique du Congo d�ment\nrepr�sent�es par leurs Pharmaciens.",
                "line_num": 406
              },
              {
                "title": "Article 19",
                "node_id": "0043",
                "summary": "This partial document, Article 19, outlines the application requirements for obtaining authorization to cultivate or produce narcotics and psychotropic substances. It specifies that all applications must be submitted to the Minister of Health.\n\nThe article details two separate but identical lists of required information: one for legal entity (corporate) applicants and one for natural person (individual) applicants. For both types of applicants, the required information includes identification details, the specifics of the proposed activity (type of drugs, seed origin, location, and area), approved private storage conditions, and the security and surveillance measures in place. The requirements for natural persons are more extensive, including personal details like marital status, gender, nationality, and legal or customary counsel.",
                "line_num": 419
              }
            ]
          },
          {
            "title": "Chapitre I : Des",
            "node_id": "0044",
            "prefix_summary": "#### Chapitre I : Des",
            "line_num": 490,
            "nodes": [
              {
                "title": "Article 1er",
                "node_id": "0045",
                "summary": "This partial document is the preamble and opening section of a ministerial decree from the Democratic Republic of the Congo. It establishes the legal and contextual foundation for regulating narcotics and psychotropic substances.\n\nThe main points covered are:\n\n1.  **Legal Basis:** It cites several existing ordinances, decrees, and ministerial orders related to government appointments and the regulation of pharmaceutical products and the commerce of narcotics.\n\n2.  **Problem Statement:** It identifies the abuse of narcotics and psychotropic substances as leading to dependency and addiction.\n\n3.  **International Justifications:** It references and considers resolutions and recommendations from global health and regulatory bodies (WHO, UNODC, INCB) that:\n    *   Urge member states to prioritize the regulation of herbal medicines.\n    *   Recommend treating drug consumption as a public health priority.\n    *   Outline strict control measures for governments authorizing cannabis cultivation for medical purposes.\n    *   Advise monitoring risks of diversion and unintended consequences from medical cannabinoid programs.\n\n4.  **Core Principles:** It establishes key considerations for the decree, including:\n    *   The indispensable nature of medical use of these substances.\n    *   The need to ensure their availability for medical and scientific purposes.\n    *   The necessity of security measures to strictly limit their cultivation, production, possession, use, and marketing to only medical and scientific ends within the DRC.\n\n5.  **Decree Introduction:** It concludes the preamble by stating the necessity and urgency of the action, formally issues the decree (\"ARRETE\"), and begins the general provisions by defining the object and scope of application in Section 1.",
                "line_num": 493
              },
              {
                "title": "Section 2 : Des",
                "node_id": "0046",
                "prefix_summary": "##### Section 2 : Des",
                "line_num": 564,
                "nodes": [
                  {
                    "title": "Article 2",
                    "node_id": "0047",
                    "summary": "###### Article 2\n\nL'exploitation des\nstup�fiants et des substances psychotropes est autoris�e � des fins\nuniquement et exclusivement m�dicales et scientifiques en R�publique\nD�mocratique du Congo, de sorte que leurs cultures, production, d�tention,\nutilisation et commercialisation � des fins autres que celles m�dicales et\nscientifiques demeurent strictement interdites.\n\nd�finitions",
                    "line_num": 567
                  },
                  {
                    "title": "Article 20",
                    "node_id": "0048",
                    "summary": "This partial document, Article 20, outlines the required components for an application to obtain authorization for the cultivation and production of plants containing narcotic and psychotropic substances for medical or scientific purposes. It specifies two separate application dossiers—one for cultivation and one for production—and lists distinct required documents for legal entities (personnes morales) and individuals (personnes physiques).\n\nThe main points covered are:\n\n1.  **Cultivation Authorization Dossier Requirements:** A detailed list of documents needed to apply for a cultivation license. For legal entities, this includes company statutes, criminal records of directors, land titles, environmental certificates, a business plan, and proof of security measures. For individuals, requirements include a land title, criminal record, a notarized contract with a pharmaceutical company, and a favorable opinion from the Local Security Committee.\n\n2.  **Production Authorization Dossier Requirements:** A similar but separate list of documents required for a production license. Legal entities must submit items like company statutes, an environmental permit, and a signed declaration restricting activity to medical/scientific purposes. For individuals, the text specifies that their entire harvest must be destined for pharmaceutical companies per a signed contract.\n\n3.  **Common Obligations for Legal Entities:** Both dossiers require legal entities to attach Environmental and Social Impact Studies (EIS) that include risk mitigation measures and to demonstrate they possess appropriate technology and qualified personnel.\n\n4.  **Core Themes:** The application process heavily emphasizes legal compliance (statutes, criminal records, registries), environmental and social responsibility (impact studies, certificates), security (specific security and surveillance measures), and the strict limitation of all activities to medical and scientific purposes.",
                    "line_num": 579
                  },
                  {
                    "title": "Article 21",
                    "node_id": "0049",
                    "summary": "###### Article 21\n\nLes dossiers de demande d�autorisation de\nculture et/ou de production des stup�fiants et des substances psychotropes\nsont trait�s par la Commission multisectorielle permanente mise en place par\nle Ministre ayant la Sant� dans ses attributions, au sein de son Minist�re,\ntel que pr�vu � l�article 98 du pr�sent Arr�t�.",
                    "line_num": 662
                  },
                  {
                    "title": "Article 22",
                    "node_id": "0050",
                    "summary": "###### Article 22\n\nLes autorisations de la culture et de la\nproduction d�livr�es par le Ministre ayant la Sant� dans ses attributions\nmentionnent :\n1. la nature de la demande de l�autorisation\n;\n2. l�identit� compl�te et l�adresse physique\nde l'exploitant ;\n3. le nom et le num�ro d'ordre du pharmacien\nresponsable ;\n4. le p�rim�tre, l'adresse de chaque lieu et\nde chaque local dans lesquels l'activit� autoris�e est r�alis�e et stock�e.\nSelon la nature de chaque stup�fiant ou\nsubstance psychotrope, elle fait l�objet d�une autorisation distincte.\nToutes autres informations compl�mentaires\naff�rentes � l�autorisation seront reprises en annexe.",
                    "line_num": 671
                  },
                  {
                    "title": "Article 23",
                    "node_id": "0051",
                    "summary": "###### Article 23\n\nLes autorisations de la culture et/ou de la\nproduction sont octroy�es pour une p�riode de cinq ans renouvelables, sauf\nrenonciation par le requ�rant, suspension, ou retrait de la licence par\nl�autorit� comp�tente.\nTout renouvellement de l'autorisation de\nculture et/ou de production fait l'objet d'une demande �crite du titulaire\nau Ministre ayant la Sant� dans ses attributions au plus tard six mois avant\nl'expiration de l'autorisation en cours.\nLes autorisations sont renouvelables apr�s\n�valuation par les services comp�tents du Minist�re ayant la Sant� dans ses\nattributions.",
                    "line_num": 690
                  }
                ]
              },
              {
                "title": "Section 2 : De la suspension et du retrait",
                "node_id": "0052",
                "prefix_summary": "##### Section 2 : De la suspension et du retrait",
                "line_num": 705,
                "nodes": [
                  {
                    "title": "Article 24",
                    "node_id": "0053",
                    "summary": "###### Article 24\n\nOutre les conditions exig�es � l'article 21\nci-dessus, le requ�rant d'une autorisation de culture et/ou de production\nest tenu de pr�senter un extrait de casier judiciaire en cours de validit�\net exempt d'une incise de condamnation en R�publique D�mocratique du Congo,\nou ailleurs, pour violation de la r�glementation sur les stup�fiants, ou sur\nle blanchiment des capitaux.\n\nde l�autorisation de la culture et/ou de la production des stup�fiants et\ndes substances psychotropes",
                    "line_num": 708
                  }
                ]
              }
            ]
          },
          {
            "title": "Chapitre IV : De la d�tention et de la",
            "node_id": "0054",
            "prefix_summary": "#### Chapitre IV : De la d�tention et de la",
            "line_num": 721,
            "nodes": [
              {
                "title": "Article 25",
                "node_id": "0055",
                "summary": "This partial document outlines the conditions under which the Minister of Health can suspend or revoke authorization for the cultivation and/or production of narcotics and psychotropic substances. The five listed conditions include: deviation from the stated purpose of the authorization; discrepancies in declared vs. actual composition of materials; non-compliance with surveillance, control, or inspection measures; unauthorized changes (major or minor); involvement in or enabling illicit trafficking due to lack of security; and violation of the decree's provisions. The text then transitions to a new section on the commercialization of these substances, beginning with a subsection on possession.",
                "line_num": 724
              },
              {
                "title": "Article 26",
                "node_id": "0056",
                "summary": "###### Article 26\n\nLa d�tention et la commercialisation des\nstup�fiants et des substances psychotropes sont soumises aux dispositions\npertinentes �dict�es par le pr�sent Arr�t�.",
                "line_num": 750
              },
              {
                "title": "Section 2 : De la commercialisation",
                "node_id": "0057",
                "prefix_summary": "##### Section 2 : De la commercialisation",
                "line_num": 757,
                "nodes": [
                  {
                    "title": "Article 27",
                    "node_id": "0058",
                    "summary": "###### Article 27\n\nNul ne peut importer, exporter, distribuer\net dispenser les stup�fiants et les substances psychotropes s'il n'est pas\npharmacien responsable, propri�taire ou non d'un �tablissement de vente en\ngros des produits pharmaceutiques, d'une exploitation industrielle, d'une\nofficine pharmaceutique ou d'un laboratoire de production autoris� par le\nMinistre ayant la Sant� dans ses attributions.",
                    "line_num": 760
                  }
                ]
              },
              {
                "title": "Section 3 : Des autorisations d'importation",
                "node_id": "0059",
                "prefix_summary": "##### Section 3 : Des autorisations d'importation",
                "line_num": 770,
                "nodes": [
                  {
                    "title": "Article 28",
                    "node_id": "0060",
                    "summary": "This partial document outlines the regulatory framework for authorizing the trade of narcotics and psychotropic substances. The main points covered are:\n\n1.  The requirement for a five-year, renewable authorization from the Minister of Health.\n2.  The authorization must specifically list the substances, establishments, and premises (or parts thereof) that are covered.\n3.  A prerequisite for issuing the authorization is verifying that the involved establishments and premises comply with security standards set by a joint ministerial decree from the Ministries of Health and Security.\n4.  The text also mentions that the authorization covers import and export activities.",
                    "line_num": 773
                  },
                  {
                    "title": "Article 29",
                    "node_id": "0061",
                    "summary": "This partial document outlines the regulatory requirements for importing narcotics and psychotropic substances into the Democratic Republic of the Congo. The main points covered are:\n\n1.  **Pre-authorization Requirement:** Importation is subject to prior authorization from the Congolese Pharmaceutical Regulatory Authority.\n2.  **Application Process:** Authorization is granted based on a separate written application for each import operation.\n3.  **Required Application Details:** The application must include specific information such as the nature, quantity, and active ingredient content of the products; the name and address of the importer and supplier; the supplier's manufacturing site; and the port of entry.\n4.  **Authorization Characteristics:** The import authorization has a serial number, is valid for six months from issuance, and its expiration date is clearly marked.\n5.  **Post-Expiration Procedure:** If unused before expiry, the authorization must be returned to the issuing authority within 30 days of its expiration date.\n6.  **Notification:** A copy of the import authorization is sent to the exporter.",
                    "line_num": 793
                  }
                ]
              }
            ]
          },
          {
            "title": "Chapitre Il : De la culture et de la production des stup�fiants",
            "node_id": "0062",
            "prefix_summary": "#### Chapitre Il : De la culture et de la production des stup�fiants",
            "line_num": 826,
            "nodes": [
              {
                "title": "Article 3",
                "node_id": "0063",
                "summary": "This partial document is Article 3 of a legal decree (Arrêté). Its main purpose is to provide official definitions for key terms used throughout the legislation. The definitions cover a wide range of concepts related to the regulation of narcotics and psychotropic substances, including:\n\n1.  **Regulatory Bodies:** Definitions for the Congolese pharmaceutical regulatory authority (ACOREP) and the National Pharmaceutical Regulatory Authority (ANRP).\n2.  **Substances & Plants:** Detailed definitions for cannabis, its resin, cannabis plants, and distinctions for medical and scientific use, as well as definitions for narcotics (stupéfiants) and psychotropic substances.\n3.  **Activities in the Supply Chain:** Definitions covering the entire cycle from cultivation (including family, family-type, and industrial scales), production, manufacturing, quality control, analysis, packaging, transportation, to wholesale and commercialization.\n4.  **Agricultural Operations:** Definitions for different types of agricultural exploitation (family, family-type, industrial), cultivators, operators, and agricultural concessions.\n5.  **Illicit Activities:** Definitions for terms like illicit trafficking, smuggling, money laundering, fraud, and concealment.\n6.  **Health & Control Terms:** Definitions for pharmaceutical products, health products, quality control, analysis certificates, addiction, and abuse.\n7.  **General Operational Terms:** Definitions for investor, funder, competent authority, major/minor change, and various other procedural terms.\n\nThe article concludes by referencing annexed tables (I-IV) listing specific controlled substances and introduces Section 1, which will cover the cultivation of narcotics.",
                "line_num": 829
              },
              {
                "title": "Article 30",
                "node_id": "0064",
                "summary": "###### Article 30\n\nL'importateur ne peut prendre possession des\nstup�fiants et substances psychotropes command�s par lui que sur\npr�sentation de l'autorisation d'importation d�livr�e par l�Autorit�\nCongolaise de R�glementation Pharmaceutique ; et ce, apr�s v�rification des\n�chantillons et pr�l�vement op�r� sur eux par un agent comp�tent pour les\nanalyses de conformit�.",
                "line_num": 1011
              },
              {
                "title": "Article 31",
                "node_id": "0065",
                "summary": "The partial document outlines the regulatory requirements for exporting narcotics and psychotropic substances from Congo. It specifies that export is contingent upon obtaining prior authorization from the Congolese pharmaceutical regulatory authority. The authorization process requires a separate written application per transaction, which must include data required for import operations and be accompanied by specific documents: a phytosanitary certificate, an analysis certificate, a certificate from the country of origin, and an import authorization from the destination country's authorities. The issued export authorization must include details such as the reference number and date of the import authorization, the issuing authority, and an export timeframe not exceeding six months. Finally, a copy of this authorization must accompany the shipment and be presented to customs at export.",
                "line_num": 1021
              },
              {
                "title": "Section 4 : Des conditions de prescription,",
                "node_id": "0066",
                "prefix_summary": "##### Section 4 : Des conditions de prescription,",
                "line_num": 1046,
                "nodes": [
                  {
                    "title": "Article 32",
                    "node_id": "0067",
                    "summary": "###### Article 32\n\nLes autorisations d'importation et\nd'exportation des stup�fiants et des substances psychotropes indiquent les\nbureaux de douane par lesquels ces op�rations auront lieu. Les autorisations\nd'importation et d'exportation non suivies d'effet doivent �tre retourn�es �\nl'autorit� qui les a d�livr�es.\n\nde d�tention et de d�livrance des stup�fiants et des substances\npsychotropes.",
                    "line_num": 1049
                  },
                  {
                    "title": "Article 33",
                    "node_id": "0068",
                    "summary": "###### Article 33\n\nIl est interdit de prescrire ou de d�livrer\nen nature les stup�fiants et les substances psychotropes.",
                    "line_num": 1061
                  },
                  {
                    "title": "Article 34",
                    "node_id": "0069",
                    "summary": "This partial document outlines the storage, security, and acquisition requirements for narcotics and psychotropic substances in pharmaceutical settings. The main points are:\n\n1.  **Storage Requirements:** Pharmacies, wholesale establishments, and manufacturing/quality control/research laboratories must have a locked cabinet, a clean room with pallets, and a refrigerator for storing these substances, following good practices.\n\n2.  **Security and Access Control:** The pharmacist is the sole holder of the keys to these storage areas, which must always be kept locked.\n\n3.  **Acquisition Procedure:** The receipt of narcotics and psychotropic substances requires a delivery note signed jointly by the responsible pharmacist and the supplier upon reception.",
                    "line_num": 1067
                  },
                  {
                    "title": "Article 35",
                    "node_id": "0070",
                    "summary": "The partial document lists the categories of persons and entities (physical and legal) who are authorized, under specific conditions, to acquire and hold narcotics and psychotropic substances for their professional needs. These authorized parties include pharmacists in public pharmacies, hospital pharmacists, wholesale distributors, and certain medical professionals like doctors, veterinarians, dentists, nurses, and midwives, each with defined qualitative and quantitative limits set by the regulatory authority ACOREP.",
                    "line_num": 1083
                  },
                  {
                    "title": "Article 36",
                    "node_id": "0071",
                    "summary": "###### Article 36\n\nL'acquisition, la d�livrance et la\ndispensation des stup�fiants et des substances psychotropes � des fins\nth�rapeutiques doivent se faire sur prescription m�dicale sign�e par le\nm�decin traitant.\nL'acquisition et la d�tention par les\nchercheurs pour des fins scientifiques sont subordonn�es � l'autorisation du\nMinistre ayant la Sant� dans ses attributions.",
                    "line_num": 1104
                  },
                  {
                    "title": "Article 37",
                    "node_id": "0072",
                    "summary": "This partial document outlines the regulatory requirements for the dispensation of narcotics. It specifies that delivery must be based on a dated and signed order form from a pharmacist, detailing the institution's information, the pharmacist's details, and the product specifics. It also lists the eight mandatory elements that must be included on the accompanying medical prescription, covering patient identity, product details, prescriber information, and institutional letterhead.",
                    "line_num": 1115
                  },
                  {
                    "title": "Article 38",
                    "node_id": "0073",
                    "summary": "###### Article 38\n\nIl est strictement interdit de c�der, ou\nd'offrir en vente, les stup�fiants et les substances psychotropes aux\npersonnes non autoris�es � les d�tenir.",
                    "line_num": 1141
                  },
                  {
                    "title": "Article 39",
                    "node_id": "0074",
                    "summary": "This partial document outlines the regulatory requirements for handling narcotics and psychotropic substances in the pharmaceutical sector. It specifies that wholesalers, importers, manufacturers, distributors, and pharmacies must record these substances in a special register approved by the Congolese Pharmaceutical Regulatory Authority (ACRP). This register must be inspected quarterly by ACRP agents. Furthermore, after any sale, dispensing, or delivery, supporting documents (specifically Part B of the order form and copies of medical prescriptions) must be submitted quarterly to the ACRP or its provincial representation.",
                    "line_num": 1148
                  },
                  {
                    "title": "Article 4",
                    "node_id": "0075",
                    "summary": "###### Article 4\n\nEst reconnu comme exploitant agricole des stup�fiants, toute personne\nphysique ou morale de droit congolais ayant obtenu au pr�alable, du Ministre\nayant la Sant� dans ses attributions, l'autorisation de culture plantes\nstup�fiantes et psychotropes � des fins m�dicales ou scientifiques.\nLa culture des plantes stup�fiantes doit r�pondre aux exigences\nphytosanitaires telles que fix�es par les textes l�gaux et r�glementaires en\nvigueur en R�publique D�mocratique du Congo.",
                    "line_num": 1166
                  },
                  {
                    "title": "Article 40",
                    "node_id": "0076",
                    "summary": "###### Article 40\n\nLes fabricants, les importateurs, les\ngrossistes et les d�taillants doivent d�poser les inventaires de stocks au\n31 d�cembre de chaque ann�e � l'Autorit� Congolaise de R�glementation\nPharmaceutique, au plus tard le 15 f�vrier de l'ann�e qui suit celle �\nlaquelle lesdits inventaires se rapportent.",
                    "line_num": 1177
                  },
                  {
                    "title": "Article 41",
                    "node_id": "0077",
                    "summary": "The partial document outlines regulations for pharmacists dispensing narcotics. The main points cover the requirement of an original, dated, signed prescription from authorized medical professionals, the mandatory details on the prescription (including renewal instructions), the pharmacist's duty to record each renewal on both the prescription and an order book, and the exceptions allowing delivery to authorized scientific laboratories, first aid kits in schools/work sites, and for supplies for voluntary indigenous medical assistance—all based on specific written requests, sometimes without a medical prescription.",
                    "line_num": 1186
                  }
                ]
              },
              {
                "title": "Section 5 : Des dispositions sur les",
                "node_id": "0078",
                "prefix_summary": "##### Section 5 : Des dispositions sur les",
                "line_num": 1214,
                "nodes": [
                  {
                    "title": "Article 42",
                    "node_id": "0079",
                    "summary": "###### Article 42\n\nLa d�tention et la cession � titre gratuit\nou on�reux des stup�fiants par des laboratoires d�analyses des produits\npharmaceutiques, et par les �tablissements de vente en gros des produits\npharmaceutiques, se font conform�ment aux Lois de la R�publique D�mocratique\ndu Congo.\n\nstup�fiants et les pr�parations qui les contiennent",
                    "line_num": 1217
                  },
                  {
                    "title": "Article 43",
                    "node_id": "0080",
                    "summary": "###### Article 43\n\nLes op�rations autoris�es portant sur les\nstup�fiants s'effectuent obligatoirement dans un �tablissement\npharmaceutique et au nom de son pharmacien titulaire.\nL'autorisation relative � chaque op�ration\nne peut pas �tre accord�e et sera �ventuellement retir�e � quiconque aura\n�t� condamn� pour trafic illicite des stup�fiants ou blanchiment des\ncapitaux.",
                    "line_num": 1228
                  },
                  {
                    "title": "Article 44",
                    "node_id": "0081",
                    "summary": "The partial document outlines regulations regarding the advertising and procurement of narcotics and psychotropic substances in the Democratic Republic of the Congo. It prohibits all advertising related to these substances and certain medications. It then details the specific authorization and procedure for a licensed pharmacist to purchase such substances from authorized wholesalers or manufacturers. This procedure mandates the use of a special three-part order form issued by the ACOREP, specifying the required information on each copy and establishing a ten-year retention period for these documents.",
                    "line_num": 1239
                  },
                  {
                    "title": "Article 45",
                    "node_id": "0082",
                    "summary": "This partial document outlines specific storage and labeling requirements for narcotic substances and preparations containing them above exemption thresholds. The main points are: 1) They must be stored in locked cabinets or rooms, with the key held by the head pharmacist. 2) These storage areas cannot contain any other substances. 3) The containers require a prominent, securely attached red label with black lettering. 4) The primary and secondary packaging must also display the word \"POISON\" in very prominent black characters on a red band encircling the container.",
                    "line_num": 1266
                  },
                  {
                    "title": "Article 46",
                    "node_id": "0083",
                    "summary": "This partial document outlines regulations for prescribing and dispensing substances listed as narcotics. It prohibits prescriptions specifying narcotics in raw form and mandates they be provided only in therapeutic pharmaceutical forms. It requires handwritten prescriptions for narcotics on special numbered forms issued by ACOREP, but exempts prescriptions for narcotics in ointment or liniment form, or at doses/concentrations below exemption thresholds.",
                    "line_num": 1284
                  },
                  {
                    "title": "Article 47",
                    "node_id": "0084",
                    "summary": "The partial document outlines the mandatory requirements for a medical prescription in a French-language context. It specifies that the prescriber's order must be dated, signed, and include legible details about the prescriber, the patient, and the prescribed medication's usage instructions. It further distinguishes between magistral (compounded) prescriptions and pharmaceutical specialties, requiring the doses of narcotic substances and the number of therapeutic units to be written out in full letters. Finally, it states that prescribers must keep the counterfoils of prescription booklets for ten years.",
                    "line_num": 1302
                  },
                  {
                    "title": "Article 48",
                    "node_id": "0085",
                    "summary": "This partial document outlines legal restrictions on prescribing and dispensing narcotics (substances on the official list of narcotics). The main points are: 1) Prescriptions for narcotics cannot exceed a seven-day supply, except for certain topical preparations. 2) Practitioners are prohibited from prescribing or renewing narcotics for the same patient within a period already covered by a previous prescription. 3) Pharmacists are prohibited from dispensing or renewing such prescriptions within that covered period, unless the prescribing practitioner explicitly notes the prior prescription on the new order.",
                    "line_num": 1319
                  },
                  {
                    "title": "Article 49",
                    "node_id": "0086",
                    "summary": "This partial document details the mandatory labeling requirements for magistral preparations (custom-made medicines) containing substances listed as narcotics and/or poisonous substances.\n\nKey points covered:\n1. The required information on the label: pharmacist's details, pharmacy address, prescription registry number, and usage instructions.\n2. The use of a specific red vignette with a black skull symbol.\n3. Different label colors (white or red) and additional warning labels based on the administration route and whether the medicine is for human use.\n4. Special labeling rules for pharmaceutical specialties (commercial products) containing narcotics or poisonous substances, involving double red lines on containers and outer packaging, along with specific information to be inscribed by the pharmacist.",
                    "line_num": 1338
                  },
                  {
                    "title": "Article 5",
                    "node_id": "0087",
                    "summary": "###### Article 5\n\nL'exploitation agricole des stup�fiants est de type industriel en R�publique\nD�mocratique du Congo.\nToute exploitation agricole non industrielle des stup�fiants est strictement\ninterdite, � condition d�en avoir obtenu l�autorisation sp�ciale aupr�s de\nl�autorit� comp�tente.",
                    "line_num": 1373
                  },
                  {
                    "title": "Article 50",
                    "node_id": "0088",
                    "summary": "###### Article 50\n\nSi la prescription magistrale ou la\nsp�cialit� pharmaceutique est destin�e � la m�decine v�t�rinaire, le\nr�cipient re�oit, en outre et dans ce cas, une �tiquette rouge portant\nimprim� en noir, la mention � usage v�t�rinaire � accompagn�e d'une vignette\nimprim�e en noir sur fond vert d�une t�te de mort.",
                    "line_num": 1382
                  },
                  {
                    "title": "Article 51",
                    "node_id": "0089",
                    "summary": "###### Article 51\n\nLes pharmaciens ne sont autoris�s � d�livrer\nles pr�parations contenant des substances inscrites � la liste des\nstup�fiants que contre remise d'une ordonnance m�dicale conforme � la loi.\nLe pharmacien a l�obligation de mentionner\nau registre des ordonnances le nom et l'adresse du malade, et,\n�ventuellement, le nom et l'adresse du tiers qui lui pr�sente l'ordonnance\npr�cit�e.",
                    "line_num": 1391
                  },
                  {
                    "title": "Article 52",
                    "node_id": "0090",
                    "summary": "###### Article 52\n\nApr�s ex�cution de la prescription, celle-ci\ndoit �tre rev�tue du timbre ou du sceau de l'officine o� elle a �t�\nex�cut�e, et comporter le num�ro sous lequel la prescription est inscrite au\nregistre d'ordonnances et la date de la d�livrance.",
                    "line_num": 1402
                  },
                  {
                    "title": "Article 53",
                    "node_id": "0091",
                    "summary": "###### Article 53\n\nLes ordonnances comportant des substances\ninscrites � la liste des stup�fiants sont conserv�es par le pharmacien\npendant 5 ans. Elles sont class�es mensuellement pour �tre pr�sent�es �\ntoute r�quisition de l'autorit� comp�tente.\nLa copie de l�ordonnance est remise au\npatient avec le num�ro d'inscription au registre d'ordonnances et la date de\nla d�livrance.\nLes ordonnances comportant des substances\ninscrites � la liste des stup�fiants � des doses et concentrations �gales ou\ninf�rieures � celles fix�es par le tableau d'exon�ration, et celles\nprescrivant lesdites substances sous forme de liniment ou de pommade peuvent\n�tre rendues au client.",
                    "line_num": 1410
                  },
                  {
                    "title": "Article 54",
                    "node_id": "0092",
                    "summary": "This partial document (Article 54) outlines regulations for renewing prescriptions of narcotic substances. It specifies that renewals are permitted only if explicitly stated on the original prescription and within defined limits (e.g., liniments/ointments, or doses/concentrations equal to or below exemption table levels). Renewals must occur after a waiting period set by the prescribing physician and must be recorded in an order register. The renewal entry in the register can reference the initial prescription by the name and quantity of the narcotic, and the renewal date and number must be noted on the prescription itself.",
                    "line_num": 1426
                  },
                  {
                    "title": "Article 55",
                    "node_id": "0093",
                    "summary": "The partial document outlines regulations for doctors and veterinarians to possess narcotics for emergency care. It specifies that the Minister of Health determines the allowed quantity and type after consulting ACOREP. The supply can be replenished based on documented usage, and all requests must be fulfilled exclusively by a designated pharmacy chosen by the prescriber. The chosen pharmacist is notified by the provincial ACOREP office.",
                    "line_num": 1449
                  },
                  {
                    "title": "Article 56",
                    "node_id": "0094",
                    "summary": "###### Article 56\n\nLes chirurgiens-dentistes\nsont mutatis mutandis autoris�s, � d�tenir pour leur usage professionnel,\ndes pr�parations contenant les substances inscrites � la liste des\nstup�fiants d�termin�es par l'ACOREP.",
                    "line_num": 1472
                  },
                  {
                    "title": "Article 57",
                    "node_id": "0095",
                    "summary": "This partial document outlines the regulatory obligations for pharmacists regarding controlled substances (narcotics). The main points covered are:\n\n1.  The requirement to retain and report physician prescriptions for controlled substances quarterly.\n2.  The mandatory use of a special, pre-approved register to record all receipts of narcotics.\n3.  The specific details required for each entry in this register (date, supplier, product, quantity).\n4.  The obligation to also record all dispensations (outgoing) of narcotics in the same register.\n5.  The rules for monthly transcription of these outgoing entries, prohibiting any alterations or blank spaces.\n6.  The minimum retention period (10 years) for this special register.",
                    "line_num": 1480
                  },
                  {
                    "title": "Article 58",
                    "node_id": "0096",
                    "summary": "###### Article 58\n\nUne fois par an au moins,\nle pharmacien d'officine proc�de � l'inventaire des substances inscrites �\nla liste des stup�fiants et des pr�parations qui les contiennent et �tablit\nla balance des entr�es et des sorties. Copies de cet inventaire et de cette\nbalance seront adress�es, d�s leur �tablissement, � la repr�sentation\nprovinciale de l'ACOREP.\nLes diff�rences\nconstat�es sont propos�es � la ratification du pharmacien de la\nrepr�sentation provinciale de l'ACOREP � l'occasion de la premi�re visite\nqui suit l'�tablissement de la balance.",
                    "line_num": 1510
                  },
                  {
                    "title": "Article 59",
                    "node_id": "0097",
                    "summary": "###### Article 59\n\nTout pharmacien, quittant\nune officine dont il est responsable, proc�de en pr�sence de son successeur,\n� l'inventaire des substances inscrites sur la liste des stup�fiants et des\npr�parations qui les contiennent. Cet inventaire est consign� sur le\npr�vu pour inscrire les\nentr�es des substances stup�fiantes.\nLe pharmacien sortant\nremet � son successeur, qui lui en donne d�charge, le registre des\nsubstances inscrites � la liste des stup�fiants et les pi�ces � conserver.",
                    "line_num": 1524
                  },
                  {
                    "title": "Article 6",
                    "node_id": "0098",
                    "summary": "###### Article 6\n\nLa superficie sur laquelle les plantes � substances stup�fiantes sont\ncultiv�es est clairement d�limit�e. Toute augmentation de cette superficie\nfait l'objet d'une autorisation pr�alable du Ministre ayant la Sant� dans\nses attributions.",
                    "line_num": 1537
                  },
                  {
                    "title": "Article 60",
                    "node_id": "0099",
                    "summary": "###### Article 60\n\nLe Ministre ayant la\nSant� dans ses attributions r�glemente la distribution gratuite aux\nm�decins, m�decins v�t�rinaires et chirurgiens-dentistes, des �chantillons\ndes sp�cialit�s pharmaceutiques contenant des substances inscrites � la\nliste des stup�fiants.",
                    "line_num": 1545
                  }
                ]
              },
              {
                "title": "Section 6 : Des",
                "node_id": "0100",
                "prefix_summary": "##### Section 6 : Des",
                "line_num": 1554,
                "nodes": [
                  {
                    "title": "Article 61",
                    "node_id": "0101",
                    "summary": "###### Article 61\n\nLes pharmaciens ne\npeuvent d�livrer les stup�fiants et les pr�parations qui les contiennent\npour l'usage de la m�decine humaine et v�t�rinaire que sur prescription d'un\nm�decin ou d'un m�decin v�t�rinaire.\n\ndispositions sur les substances psychotropes",
                    "line_num": 1557
                  },
                  {
                    "title": "Article 62",
                    "node_id": "0102",
                    "summary": "This partial document outlines specific storage and labeling requirements for psychotropic substances and preparations containing them. Key points include: mandatory secure storage accessible only to designated pharmacy personnel; labeling of containers with the psychotropic substance's official name from the list; and the use of highly visible black characters on a green label that is securely attached. Furthermore, the label must include the word \"dangereux\" (dangerous) in prominent black letters on a green strip encircling the container or packaging, and it must appear on thermoformed blister packs and secondary packaging.",
                    "line_num": 1567
                  },
                  {
                    "title": "Article 63",
                    "node_id": "0103",
                    "summary": "###### Article 63\n\nLe prescripteur est tenu\nde dater, de signer la prescription contenant des substances de la liste des\nsubstances psychotropes, et d'y mentionner son nom, son adresse, son num�ro\nd'ordre, le nom et l'adresse de l'�tablissement hospitalier, le nom et\nl'adresse du patient ainsi que le mode d'administration du m�dicament.",
                    "line_num": 1586
                  },
                  {
                    "title": "Article 64",
                    "node_id": "0104",
                    "summary": "###### Article 64\n\nApr�s ex�cution de la\nprescription, elle est rendue au client, rev�tue du timbre ou du sceau de\nl'officine o� elle a �t� ex�cut�e, et porte le num�ro sous lequel ladite\nprescription est inscrite au registre d'ordonnances et la date de la\nderni�re d�livrance. Le pharmacien peut cependant conserver l'ordonnance\ndans les conditions pr�vues par le pr�sent Arr�t�.",
                    "line_num": 1595
                  },
                  {
                    "title": "Article 65",
                    "node_id": "0105",
                    "summary": "###### Article 65\n\nLes conditionnements dans\nlesquels sont livr�s les produits ou les pr�parations non sp�cialis�s\ncontenant une ou plusieurs substances inscrites � la liste des substances\npsychotropes, portent une �tiquette appropri�e.\nSi le m�dicament est\ndestin� � la m�decine humaine et � �tre administr� par les voies orale,\nperlinguale ou transcutan�e, l'�tiquette est blanche, imprim�e en noir sur\nfond rouge portant la mention � ne pas d�passer la dose prescrite �.",
                    "line_num": 1605
                  },
                  {
                    "title": "Article 66",
                    "node_id": "0106",
                    "summary": "###### Article 66\n\nLes sp�cialit�s\npharmaceutiques contenant une ou plusieurs substances inscrites � la liste\ndes substances psychotropes sont �tiquet�es selon la r�glementation des\nautres sp�cialit�s.\nEn outre, l'�tiquette de\nl'emballage ext�rieur comporte un cadre de couleur verte m�nageant un espace\nblanc dans lequel le pharmacien d'officine inscrit :\n1. son nom, son adresse\net l'adresse physique de l�officine ;\n2. son num�ro d'ordre ;\n3. le num�ro d'inscription au registre\nd'ordonnances ;\n4. le mode d'emploi indiqu� par l'auteur de\nla prescription.",
                    "line_num": 1617
                  },
                  {
                    "title": "Article 67",
                    "node_id": "0107",
                    "summary": "###### Article 67\n\nSi le m�dicament est destin� � la m�decine\nv�t�rinaire, il portera une �tiquette verte sur laquelle est imprim�e en\nnoir la mention � usage v�t�rinaire �.",
                    "line_num": 1635
                  }
                ]
              },
              {
                "title": "Section 7 : Des dispositions applicables aux",
                "node_id": "0108",
                "prefix_summary": "##### Section 7 : Des dispositions applicables aux",
                "line_num": 1642,
                "nodes": [
                  {
                    "title": "Article 68",
                    "node_id": "0109",
                    "summary": "###### Article 68\n\nLes prescriptions comportant des substances\ninscrites � la liste des substances psychotropes sont renouvelables, sauf\nindication contraire de l'auteur de la prescription, apr�s un d�lai\nd�termin� par le mode d'emploi du m�dicament.\nLes renouvellements d'une ordonnance sont\nmentionn�s sur le registre des ordonnances sous un num�ro d'ordre. Cette\ninscription peut se limiter � la seule indication du num�ro sous lequel\nl'ordonnance a �t� initialement inscrite avec mention de la date et du\nnum�ro du renouvellement.\n\ntransports commerciaux",
                    "line_num": 1645
                  },
                  {
                    "title": "Article 69",
                    "node_id": "0110",
                    "summary": "###### Article 69\n\nLes transporteurs commerciaux sont tenus de\nprendre les dispositions qui s�imposent pour que leurs moyens de transport\nne servent pas au trafic illicite des stup�fiants et des substances\npsychotropes.\nIls sont notamment tenus de :\n1. d�poser les manifestes de transport �\nl'avance aupr�s des services comp�tents du Minist�re ayant la Sant� dans ses\nattributions et d�clarer les contenus des colis suivant leurs d�nominations\ninternationales ;\n2. enfermer lesdits colis dans des\nconteneurs plac�s sous scell�s infalsifiables et susceptibles d'un contr�le\ndistinct ;\n3. informer les autorit�s comp�tentes, de\ntoutes situations pouvant faire suspecter tout trafic illicite.",
                    "line_num": 1660
                  },
                  {
                    "title": "Article 7",
                    "node_id": "0111",
                    "summary": "###### Article 7\n\nL'autorisation de culture de plantes\nstup�fiantes est accord�e par le Ministre ayant la Sant� dans ses\nattributions, qui en informe les Services membres de la Commission\nMultisectorielle Permanente. Une copie de cette autorisation est transmise\naux Ministres ayant respectivement la S�curit�, l�Environnement, et\nl�Agriculture dans leurs attributions.\nL'autorisation de culture vis�e � l'article\n7 �num�re limitativement les plantes concern�es, d�termine la superficie �\ncultiver, et fixe les conditions particuli�res y aff�rentes.",
                    "line_num": 1678
                  },
                  {
                    "title": "Article 70",
                    "node_id": "0112",
                    "summary": "###### Article 70\n\nIl est interdit de transporter les\nstup�fiants et les substances psychotropes pour le compte d'une personne non\nautoris�e en vertu du pr�sent Arr�t�.",
                    "line_num": 1691
                  }
                ]
              }
            ]
          },
          {
            "title": "Chapitre V : De l'usage m�dical et",
            "node_id": "0113",
            "prefix_summary": "#### Chapitre V : De l'usage m�dical et",
            "line_num": 1698,
            "nodes": [
              {
                "title": "Article 71",
                "node_id": "0114",
                "summary": "This partial document outlines regulations for the handling and transport of narcotics and psychotropic substances. It specifies that these substances must be contained in glass or metal vessels, clearly labeled with their contents as per the official list. The containers must also bear a distinctive red-orange label with a skull and crossbones and the word \"Poison\" in black. Furthermore, the sender's and recipient's names and addresses must be visibly and legibly displayed on the containers during transport. The text then introduces a new section on the medical use of narcotics and psychotropic substances.",
                "line_num": 1701
              },
              {
                "title": "Article 72",
                "node_id": "0115",
                "summary": "###### Article 72\n\nL'usage hors prescription m�dicale des\nstup�fiants ou des substances psychotropes est interdit en R�publique\nD�mocratique du Congo.\nSeuls les m�decins dipl�m�s et titulaires de\nl'autorisation d'exercer sont autoris�s � prescrire ce type des m�dicaments.\nIl en est de m�me pour le m�decin\nv�t�rinaire et le chirurgien-dentiste ainsi que pour le pharmacien qui\nd�livre lesdits m�dicaments.",
                "line_num": 1723
              },
              {
                "title": "Article 73",
                "node_id": "0116",
                "summary": "###### Article 73\n\nSeules les industries\npharmaceutiques d�tentrices de l'autorisation de fabriquer les m�dicaments �\nbase de stup�fiants et des substances psychotropes peuvent s'approvisionner\nen intrants correspondants.\nL�approvisionnement ne\npeut avoir lieu qu'aupr�s de l'exploitant agricole ou d'un producteur\nindustriel titulaire d'une autorisation.",
                "line_num": 1735
              }
            ]
          },
          {
            "title": "Livre II",
            "node_id": "0117",
            "prefix_summary": "### Livre II",
            "line_num": 1746,
            "nodes": [
              {
                "title": "Article 74",
                "node_id": "0118",
                "summary": "###### Article 74\n\nTout m�decin ou m�decin\nv�t�rinaire qui aura acquis ou prescrit des doses exag�r�es de ces\nsubstances, doit justifier de leur emploi devant une commission de deux\nm�decins d�sign�s par le m�decin chef de la Division Provinciale de la\nSant�.\nTout praticien qui aura,\nsans n�cessit�, prescrit, administr� ou procur� des stup�fiants et des\nsubstances psychotropes de mani�re � cr�er, � entretenir ou � aggraver une\ntoxicomanie, est passible des peines pr�vues par le Code P�nal Congolais\n et la Loi n�18/035 du 13 d�cembre 2018.",
                "line_num": 1749
              },
              {
                "title": "Article 75",
                "node_id": "0119",
                "summary": "###### Article 75\n\nAucune des substances ou\npr�parations contenant une dose si minime soit-elle des substances vis�es\npar le pr�sent Arr�t� ne peut �tre d�livr�e sans prescription m�dicale\nsp�ciale, ni offerte, ni expos�e en vente lorsque cette substance ou cette\npr�paration est destin�e � des enfants de moins de 3 ans.",
                "line_num": 1763
              },
              {
                "title": "Article 76",
                "node_id": "0120",
                "summary": "###### Article 76\n\nSans pr�judice de\nl'application des peines pr�vues par le Code p�nal congolais, livre II,\ntoute personne qui se sera procur�e ou aura tent� de se procurer des\nstup�fiants ou des substances psychotropes au moyen d'une fausse ordonnance,\nd'une fausse demande, d'une fausse signature ou par quelque autre moyen\nfrauduleux que ce soit, est passible des peines pr�vues � l'article 132 de\nla Loi n�18/035 du 13 d�cembre 2018 fixant les principes fondamentaux\nrelatifs � l'organisation de la Sant� publique.",
                "line_num": 1772
              },
              {
                "title": "Section 2 : De l'usage",
                "node_id": "0121",
                "prefix_summary": "##### Section 2 : De l'usage",
                "line_num": 1784,
                "nodes": [
                  {
                    "title": "Article 77",
                    "node_id": "0122",
                    "summary": "###### Article 77\n\nLe pharmacien est\nautoris� � d�livrer exceptionnellement, de son propre chef, et � titre de\nm�dicament d'urgence :\n1) la teinture d'opium ;\n2) le laudanum de\nSydenham ;\n3) la poudre de Dower.\nToutefois, la quantit�\nmaximale d�livr�e, de l�un ou l�autre de ces produits, ne peut �tre\nsup�rieure � 2,5g.\nLe pharmacien �tablit un\nbon de sortie qui sp�cifie le nom de l'acheteur, et y marque la mention �\nd�livr� en cas d'urgence � et transcrit cette sortie au livre d'ordonnances.\n\nscientifique des stup�fiants et des substances psychotropes",
                    "line_num": 1787
                  },
                  {
                    "title": "Article 78",
                    "node_id": "0123",
                    "summary": "###### Article 78\n\nEst permis d'utiliser les\nstup�fiants et les substances psychotropes � des fins scientifiques, toute\npersonne morale ou physique engag�e dans la conduite d'�tudes ou de\nrecherches scientifiques dans un laboratoire rattach� � une universit�, � un\nh�pital, ou � une institution � caract�re scientifique et dont les activit�s\nsont reconnues par les Ministres ayant dans leurs attributions respectives\nla Recherche Scientifique, l'Enseignement Sup�rieur et Universitaire, et la\nSant�.",
                    "line_num": 1806
                  },
                  {
                    "title": "Article 79",
                    "node_id": "0124",
                    "summary": "###### Article 79\n\nToute personne vis�e aux\narticles 19 et 20 du pr�sent Arr�t� adresse une demande d'autorisation\nd'utilisation des stup�fiants et des substances psychotropes, pour des fins\nscientifiques, au Ministre ayant la Sant� dans ses attributions.",
                    "line_num": 1818
                  }
                ]
              },
              {
                "title": "Section 2 : De la production des stup�fiants",
                "node_id": "0125",
                "prefix_summary": "##### Section 2 : De la production des stup�fiants",
                "line_num": 1826,
                "nodes": [
                  {
                    "title": "Article 8",
                    "node_id": "0126",
                    "summary": "###### Article 8\n\nLe Ministre ayant la Sant� dans ses\nattributions v�rifie conform�ment � la proc�dure si les concessions sur\nlesquelles les cultures industrielles seront pratiqu�es sont obtenues sur\nbase de la l�gislation en vigueur, notamment la Loi n�11/022 du 24 d�cembre\n2011 portant principes fondamentaux relatifs � l'agriculture, et la Loi\nn�73-021 du 20 juillet 1973 portant r�gime g�n�ral des biens, r�gime foncier\net immobilier et r�gime des s�ret�s, telle que modifi�e et compl�t�e � ce\njour.\n\net des substances psychotropes",
                    "line_num": 1829
                  },
                  {
                    "title": "Article 80",
                    "node_id": "0127",
                    "summary": "###### Article 80\n\nLa demande d'autorisation\nde recherche sp�cifie :\n1) l'identit� compl�te du\nrequ�rant ;\n2) l'objet pour lequel\nl'autorisation est sollicit�e ;\n3) l'attestation de l'institution d'attache\ndu requ�rant ou le permis de recherche s'il s'agit d'un ind�pendant ;\n4) les mesures n�cessaires garantissant :\na) l'utilisation et la garde correcte des\nintrants ou des plantes stup�fiantes et des substances psychotropes ;\nb) la conservation ad�quate des dossiers de\nla gestion des stup�fiants, des substances psychotropes et des intrants ;\n5) Tout autre d�tail requis au regard de\nl'importance du sujet.",
                    "line_num": 1843
                  }
                ]
              },
              {
                "title": "Section 3 : De la trousse de secours",
                "node_id": "0128",
                "prefix_summary": "##### Section 3 : De la trousse de secours",
                "line_num": 1862,
                "nodes": [
                  {
                    "title": "Article 81",
                    "node_id": "0129",
                    "summary": "###### Article 81\n\nLe titulaire de l'autorisation de recherche\nest tenu de faire rapport au Ministre ayant la Sant� dans ses attributions\nsur la gestion des intrants ou des plantes stup�fiantes et des substances\npsychotropes dans la recherche, y compris les d�tails sur les quantit�s\nacquises, utilis�es, �limin�es et encore d�tenues.\n\nd'urgence et des moyens de transport",
                    "line_num": 1865
                  }
                ]
              },
              {
                "title": "Chapitre VI : De la classification des",
                "node_id": "0130",
                "prefix_summary": "#### Chapitre VI : De la classification des",
                "line_num": 1876,
                "nodes": [
                  {
                    "title": "Article 82",
                    "node_id": "0131",
                    "summary": "This partial document excerpt from a legal or regulatory text outlines conditions under which a national minister can authorize the carriage of small quantities of certain controlled medications (listed in tables II and III) on registered public transport vessels, aircraft, and other vehicles undertaking international or intercity routes. The authorization is limited to a supply for emergency first aid. It specifies that the authorization, granted upon request from the transport operator, establishes measures to prevent misuse and diversion for illicit purposes. The authorization details the responsible crew members, the storage conditions, the accounting procedures for withdrawals and replacements, and the reporting modalities for periodic usage reports by the operator. It clarifies that administering these medications in an emergency is not considered a violation of the referenced legal sections. The text mentions these medications relate to narcotics, psychotropic substances, and preparations containing them.",
                    "line_num": 1879
                  },
                  {
                    "title": "Article 83",
                    "node_id": "0132",
                    "summary": "###### Article 83\n\nLes stup�fiants, les substances\npsychotropes, et les pr�parations qui les contiennent vis�s par le pr�sent\nArr�t� sont class�s dans les tableaux I, II et III, en annexe, suivant les\nmesures de contr�le auxquelles ils sont soumis.",
                    "line_num": 1902
                  },
                  {
                    "title": "Article 84",
                    "node_id": "0133",
                    "summary": "This partial document defines a system for classifying narcotic and psychotropic plants and substances, as well as other dangerous substances, into three tables based on two criteria: the severity of public health risk from abuse and whether they have medical value. The tables are Table I (high risk, no medical use), Table II (high risk, with medical use), and Table III (risk, with medical use). It further specifies that Tables II and III are subdivided into groups A and B to determine applicable measures.",
                    "line_num": 1910
                  },
                  {
                    "title": "Article 85",
                    "node_id": "0134",
                    "summary": "###### Article 85\n\nLes plantes et les substances sont inscrites\nsous leur d�nomination commune internationale ou, � d�faut, sous leur\nd�nomination chimique et scientifique.",
                    "line_num": 1930
                  },
                  {
                    "title": "Article 86",
                    "node_id": "0135",
                    "summary": "###### Article 86\n\nSont consid�r�s comme pr�parations, et\nsoumis au m�me r�gime que les substances qu'elles renferment, les\nm�langes solides ou liquides\ncontenant une ou\nplusieurs substances class�es sous contr�le, et les substances psychotropes\ndivis�es en unit�s de prise.\nLes pr�parations\ncontenant deux substances ou plus, assujetties � des r�gimes diff�rents,\nsont soumises au r�gime de la substance strictement contr�l�e.",
                    "line_num": 1937
                  }
                ]
              },
              {
                "title": "Chapitre VII : De la",
                "node_id": "0136",
                "prefix_summary": "#### Chapitre VII : De la",
                "line_num": 1950,
                "nodes": [
                  {
                    "title": "Article 87",
                    "node_id": "0137",
                    "summary": "The partial document covers provisions regarding the control of preparations containing substances listed in specific tables (I, II, and III). It outlines conditions under which certain preparations can be exempted from control measures, the prohibition of preparations containing Table I substances, and the authority of ACOREP to modify the tables. It also introduces a section on surveillance and inspection.",
                    "line_num": 1953
                  },
                  {
                    "title": "Article 88",
                    "node_id": "0138",
                    "summary": "This partial document outlines the regulatory powers of ACOREP regarding controlled substances. The main points covered are: 1) ACOREP's annual responsibility to set maximum cultivation, production, possession, and sales quotas for plants with narcotic or psychotropic substances for the following year, based on expressed needs. 2) ACOREP's authority to modify an individual license holder's quota at any time. 3) The requirement that any quota modification must be formally and immediately communicated in writing to the affected license holder.",
                    "line_num": 1973
                  },
                  {
                    "title": "Article 89",
                    "node_id": "0139",
                    "summary": "This partial document covers Article 89 of a regulation. Its main points are the mandatory reporting requirements for individuals or companies handling specific plants, substances, and preparations. They must submit to the regulatory authority (ACOREP):\n1. A quarterly report on imported/exported quantities of each substance and preparation, including sender/destination countries, due within 10 days after each quarter.\n2. An annual report, due by February 15th for the previous calendar year, detailing:\n   - Quantities produced or manufactured.\n   - Quantities used to make other regulated substances, exempt preparations, or non-regulated substances.\n   - Quantities consumed or supplied for retail distribution for medical use or scientific research.\n   - Quantities held in stock as of December 31st.",
                    "line_num": 1990
                  },
                  {
                    "title": "Article 9",
                    "node_id": "0140",
                    "summary": "###### Article 9\n\nEst reconnu comme producteur des stup�fiants\net des substances psychotropes vis�s � l'article 2 du pr�sent Arr�t�, toute\npersonne morale de droit congolais qui remplit les conditions pr�vues par le\npr�sent Arr�t�.",
                    "line_num": 2018
                  },
                  {
                    "title": "Article 90",
                    "node_id": "0141",
                    "summary": "###### Article 90\n\nLe suivi de gestion des\nstup�fiants et des substances psychotropes est effectu� trimestriellement\npar l'ACOREP.",
                    "line_num": 2026
                  },
                  {
                    "title": "Article 91",
                    "node_id": "0142",
                    "summary": "The partial document outlines the inspection and enforcement powers of ACOREP (a regulatory body). It states that ACOREP's inspectors can monitor compliance with the decree at any time. Specifically, an inspector can order any person authorized to handle narcotics and psychotropic substances under the decree to provide specified documents, information, or samples for the purpose of verifying compliance or preventing non-compliance.",
                    "line_num": 2033
                  },
                  {
                    "title": "Article 92",
                    "node_id": "0143",
                    "summary": "###### Article 92\n\nToute personne titulaire\nd'une autorisation d�livr�e en vertu du pr�sent Arr�t�, lorsque cela est requis\npar �crit par un inspecteur, est tenue de fournir imm�diatement � ce dernier une\nd�claration �crite, sign�e et dat�e. Cette d�claration indique chaque\nstup�fiant, chaque produit chimique et chaque �quipement ou mati�re sous\ncontr�le en sa possession depuis la demande et l'octroi de l'autorisation.",
                    "line_num": 2048
                  },
                  {
                    "title": "Section 2 : Du contr�le",
                    "node_id": "0144",
                    "prefix_summary": "##### Section 2 : Du contr�le",
                    "line_num": 2058,
                    "nodes": [
                      {
                        "title": "Article 93",
                        "node_id": "0145",
                        "summary": "###### Article 93\n\nToute personne charg�e de la\nsurveillance et de l'inspection, munie d'un ordre de mission peut, � tout\nmoment, pendant les heures normales de service, et si les n�cessit�s de l'ordre\net de la s�curit� publics le r�clament, p�n�trer, avec l'aide des agents de\nl'ordre, dans des locaux ou des lieux o� toute activit� s'effectue par toute\npersonne qui a obtenu une autorisation en vertu du pr�sent Arr�t�.\nL�agent commis � la\nsurveillance et � l�inspection pr�l�ve, aux fins d'examen, des �chantillons des\nproduits qui lui paraissent suspects.",
                        "line_num": 2061
                      },
                      {
                        "title": "Article 94",
                        "node_id": "0146",
                        "summary": "This partial document outlines the powers and procedures of inspectors from ACOREP (the regulatory authority) in controlling narcotics and psychotropic substances. It specifies that agricultural operators, industrial producers, wholesalers, and pharmaceutical entities handling these substances are subject to ACOREP's control.\n\nThe main points covered are the inspectors' rights to conduct unannounced inspections at any location where these substances are handled and a detailed list of their specific powers during these inspections. These powers include:\n1.  Requesting the identity and address of the premises' occupant.\n2.  Inspecting the locations for regulatory compliance.\n3.  Examining all related labels, advertising, registers, electronic data, and other documents.\n4.  Copying documents and demanding explanations of entries.\n5.  Opening and examining any container or packaging to search for traces of controlled substances.\n6.  Searching for anything used in the manufacture, packaging, or storage of these substances.\n7.  Examining substances found, taking samples for analysis.\n8.  Seizing and detaining any object that may serve as evidence of a violation of the Arrêté (the regulation).",
                        "line_num": 2074
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Chapitre VIII : De",
                "node_id": "0147",
                "prefix_summary": "#### Chapitre VIII : De",
                "line_num": 2113,
                "nodes": [
                  {
                    "title": "Article 95",
                    "node_id": "0148",
                    "summary": "###### Article 95\n\nSous peine de sanctions\nappropri�es, nul ne peut, ni par action ni par omission, faire obstruction �\nl�exercice des fonctions conf�r�es aux inspecteurs en vertu du pr�sent Arr�t�,\nou refuser de leur fournir toutes les informations dont ils ont besoin dans le\ncadre des enqu�tes impos�es par la loi et le pr�sent texte r�glementaire.\n\nl�exploitation du cannabis � des fins m�dicales et scientifiques\nSection 1 : De la\nCoordination",
                    "line_num": 2116
                  },
                  {
                    "title": "Section 2 : De la Culture de",
                    "node_id": "0149",
                    "prefix_summary": "##### Section 2 : De la Culture de",
                    "line_num": 2129,
                    "nodes": [
                      {
                        "title": "Article 96",
                        "node_id": "0150",
                        "summary": "This partial document outlines the legal establishment and mandate of a permanent multi-sectoral commission in the Democratic Republic of the Congo. It is created by the Minister of Health, based on international drug control conventions. The commission's primary mission is to coordinate and facilitate activities for the development of the **cannabis industry** within the country, working in collaboration with the Ministry of Foreign Trade.",
                        "line_num": 2132
                      },
                      {
                        "title": "Article 97",
                        "node_id": "0151",
                        "summary": "###### Article 97\n\nEst exploitant agricole du\ncannabis, toute personne physique ou morale de droit congolais ayant, au\npr�alable, obtenu du Minist�re ayant la Sant� dans ses attributions,\nl'autorisation de culture de la plante de cannabis � des fins m�dicales ou\nscientifiques.\nLes Associations sans but\nlucratif (Asbl) ne sont pas concern�es par l�alin�a premier du pr�sent article.",
                        "line_num": 2149
                      },
                      {
                        "title": "Article 98",
                        "node_id": "0152",
                        "summary": "###### Article 98\n\nTout op�rateur du secteur du\ncannabis participe financi�rement au d�veloppement �conomique du milieu o�\ns�exercent ses activit�s, conform�ment au contrat.\nIl c�de 30% des parts ou\nactions dans le capital social aux ressortissants congolais d�origine par les\nm�canismes du portage remboursable.\nIl rapatrie 40% de ses\nrevenus d�exportation dans un d�lai de 90 jours par le biais de la Banque\nCentrale du Congo.\nLes 40% rapatri�s sont\nr�investis au pays dans un programme commun avec le Gouvernement dans le cadre\nd�un Partenariat Public Priv�, conform�ment � un contrat sp�cifique avec le\nMinist�re concern�.",
                        "line_num": 2160
                      },
                      {
                        "title": "Article 99",
                        "node_id": "0153",
                        "summary": "###### Article 99\n\nPour la culture de la plante\nde cannabis, les exigences phytosanitaires conformes aux textes en vigueur en\nR�publique D�mocratique du Congo sont de mise.",
                        "line_num": 2177
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "node_article_mapping": {
    "0001": [
      "2de59ee1-a42c-4f11-bcb2-bdc9137cd1ca"
    ],
    "0002": [
      "cc2fca18-80ac-4cc4-a899-77545a953306"
    ],
    "0003": [
      "755c27e0-4a03-4c05-92eb-56fb36ad703f"
    ],
    "0004": [
      "a7aa938b-449e-4c1c-9d65-103f02ebab53"
    ],
    "0006": [
      "1cc0c60a-e865-477e-9ed5-484c1be695bb"
    ],
    "0007": [
      "2eb18bb2-7aec-4039-a629-e9a1d0503282"
    ],
    "0008": [
      "f86fe82c-cf9f-45e0-b485-ac87757fbade"
    ],
    "0010": [
      "e96f59d6-e06a-4d8d-89c2-c932192cae2c"
    ],
    "0011": [
      "62649ee3-5631-4fc5-bdfe-a8edd370f230"
    ],
    "0012": [
      "baf1c8bf-5dcd-4c45-8e26-f4af92286454"
    ],
    "0013": [
      "874960ee-7b25-4b7f-8515-36d3bb26feef"
    ],
    "0014": [
      "bf10a0b1-0a6a-49ab-b649-2a0cd2a70c6c"
    ],
    "0015": [
      "4c8f02c8-30a7-4b68-9273-e4e01256eb77"
    ],
    "0017": [
      "ec2eb62e-9437-4e47-b431-cbecb8da0dcc"
    ],
    "0018": [
      "0ea410f1-187b-4b25-8b46-fcf9cafc2fdd"
    ],
    "0019": [
      "57823a25-ed94-4ecd-a9d9-8308463fc4d8"
    ],
    "0021": [
      "11c34175-6b8c-41c6-a98b-0275490562a8"
    ],
    "0022": [
      "e4b83eec-8618-44c5-9c98-4d5feaf98e2e"
    ],
    "0024": [
      "7b04fbd4-6d89-4975-a150-02cda8c3dacc"
    ],
    "0025": [
      "212b204b-cbd7-4227-8ea8-04707a1b5493"
    ],
    "0026": [
      "74ac6860-92fe-42e2-a8c2-172a166e2d50"
    ],
    "0028": [
      "0ea2a2c0-631c-4a40-a64f-a287a5880e4c"
    ],
    "0029": [
      "56f83449-4c32-4595-8606-f58a6801c063"
    ],
    "0030": [
      "95e2cbcd-4025-4de2-9a6e-e503db4c89c2"
    ],
    "0031": [
      "19196f94-343b-44d6-ad67-6cbffc96ceb5"
    ],
    "0033": [
      "6129ef94-d80f-479e-9f9e-44a9e8bc51c7"
    ],
    "0034": [
      "f32a519e-f8ab-4aa9-9ab0-9866fd62e33b"
    ],
    "0035": [
      "6a551250-3fba-41c9-bbfe-a3423f851f93"
    ],
    "0036": [
      "887251c2-0dc6-4433-bb34-bc96b6978750"
    ],
    "0037": [
      "e79a7e88-f3cc-4a09-8ad9-6e4a1e0c9b8d"
    ],
    "0038": [
      "328636cf-78ee-47ed-b2b6-8302b6239b76"
    ],
    "0039": [
      "889ebdc0-221a-4c72-bf75-4be62b12a887"
    ],
    "0041": [
      "3d23ef0c-099a-4f58-b771-b3738409d0ae"
    ],
    "0042": [
      "d5506816-9f19-4352-b0db-c48df04a00e6"
    ],
    "0043": [
      "26ce2d17-ab34-43b6-835d-26e2ed652414"
    ],
    "0045": [
      "080d5940-e167-42c9-a76b-38cb6fdb86a1"
    ],
    "0047": [
      "fede24ff-09c7-4bee-b4f8-8a058b950622"
    ],
    "0048": [
      "84c34cf0-3c99-409d-ad3e-66e180e73ba1"
    ],
    "0049": [
      "721cc2a5-2645-400a-b5e1-4cab7f12d479"
    ],
    "0050": [
      "b0d8a575-65ee-47e0-b2a0-1655e16895ef"
    ],
    "0051": [
      "49cc0ed7-a700-4509-99a8-0aa73bf1dbb8"
    ],
    "0053": [
      "f92be37a-e600-411b-8a3b-e3c86887b025"
    ],
    "0055": [
      "7fa2be30-1262-46d4-8fc0-7ef8afe6144c"
    ],
    "0056": [
      "bb526e46-2be2-48ef-9cab-ac0012e8d663"
    ],
    "0058": [
      "42dc3f1f-eda3-4e4a-aee4-6e2cded51f4a"
    ],
    "0060": [
      "810ce82f-8a47-481e-b329-c9b4acef75ee"
    ],
    "0061": [
      "edd3acd7-f871-49e8-b7ea-12b26b92a7af"
    ],
    "0063": [
      "3e5cdf49-383b-4ac5-a62b-e389d1d9193a"
    ],
    "0064": [
      "92e0b03e-db1e-46e1-aa56-039beeb5aaf6"
    ],
    "0065": [
      "19677431-2107-44e5-aa15-21b72bfbe134"
    ],
    "0067": [
      "dde50c6a-a294-4f43-a274-20d5296a3f74"
    ],
    "0068": [
      "4165121d-5462-4cd8-8165-a7b6abce1180"
    ],
    "0069": [
      "4b4bd53d-490d-4cff-bba0-7e10535b813c"
    ],
    "0070": [
      "09119a68-5fcd-4745-8c4e-c974fde67e1e"
    ],
    "0071": [
      "dad87f1d-32e6-4e46-8f73-48ce12eb2fc1"
    ],
    "0072": [
      "b5077eea-9ff2-4e41-882b-c74af2bf9a7f"
    ],
    "0073": [
      "01cd4006-abeb-445c-9243-a3f82d3d415f"
    ],
    "0074": [
      "bab60ad0-fcd6-4bcb-aae9-4a6d3dd7cac0"
    ],
    "0075": [
      "3294997c-ea63-4f0e-b86f-47a4b725dda9"
    ],
    "0076": [
      "45e7b4cd-b647-4d1f-b680-b0581efb2c5b"
    ],
    "0077": [
      "e49c594a-70cb-4caf-bf89-0a571fc74884"
    ],
    "0079": [
      "dfc8d8db-4013-40ed-ae42-75c5086d7896"
    ],
    "0080": [
      "983bf348-386e-4ebd-8f61-f2e5258224bc"
    ],
    "0081": [
      "abda036c-0731-40cc-8c1f-3530806eb2a4"
    ],
    "0082": [
      "7d220d65-be40-4089-8c99-6d415e6f7f32"
    ],
    "0083": [
      "a8a51f30-cbf5-49e6-809a-c676823b1de5"
    ],
    "0084": [
      "94a18d00-9c01-4706-a778-d3922825fdb5"
    ],
    "0085": [
      "92f27f53-96a0-4c28-bc79-f5b661d303a2"
    ],
    "0086": [
      "0634e517-97ab-4371-a1d3-7ed2b5b86a4a"
    ],
    "0087": [
      "594fe474-f2a1-4aea-81a2-950c35f84aa8"
    ],
    "0088": [
      "2dd728f1-86a0-4322-9908-6441c3840eae"
    ],
    "0089": [
      "3ad43ec6-038c-4a20-8199-caa409afbf4e"
    ],
    "0090": [
      "c816d698-46eb-4395-b5f7-fb55b8519ef5"
    ],
    "0091": [
      "ac89357a-764c-40b1-beec-ca8d3d1fd2d3"
    ],
    "0092": [
      "f19f0df9-206e-4f89-a56c-2a8ccec1dda7"
    ],
    "0093": [
      "de96fc1c-18ac-4018-a3a9-79171421fe24"
    ],
    "0094": [
      "14f05734-d4ec-4fa0-a033-224d2163715b"
    ],
    "0095": [
      "72e9b9cf-661a-4a7f-ace0-5af449fdf0cd"
    ],
    "0096": [
      "1f11842b-8357-4168-b89b-493171a11928"
    ],
    "0097": [
      "13b0aa56-a9a8-40a9-9e2f-da8a02ae24a7"
    ],
    "0098": [
      "e77734f4-b400-4403-8a32-29e07d5d942d"
    ],
    "0099": [
      "27899da4-c42a-48c6-9f25-50a0cae91b5f"
    ],
    "0101": [
      "6ae0a739-ac9e-4c14-b2ea-db6dd6eb9014"
    ],
    "0102": [
      "c5035517-6df1-4b4e-b386-fc1334baa847"
    ],
    "0103": [
      "ba7cac27-f143-4e17-b272-e65563f9cf5e"
    ],
    "0104": [
      "893fcdba-ab05-4575-a215-eb98cfcb5c02"
    ],
    "0105": [
      "3ea37844-d99b-4561-a0ab-a799b63d0eb2"
    ],
    "0106": [
      "69e6b6b8-e153-4bc3-8368-2c6d841df817"
    ],
    "0107": [
      "e06151ed-91f6-4fa0-b116-a263d86f93cb"
    ],
    "0109": [
      "1b03db77-e8e9-4eaf-abed-8da354eda2bb"
    ],
    "0110": [
      "4bbcc3ab-6ad3-4ca9-adeb-2af0c7203560"
    ],
    "0111": [
      "ef8e85b2-abf2-419c-b113-e07fcfe19c97"
    ],
    "0112": [
      "cef8fa94-1440-4aac-9740-31646530a767"
    ],
    "0114": [
      "58a9ff2a-61e6-4a83-8b31-d8a134302609"
    ],
    "0115": [
      "e473f709-72b1-4f94-bb34-1de153a0f548"
    ],
    "0116": [
      "745d3de0-63c5-4744-9e43-dce77a4829d0"
    ],
    "0118": [
      "84c655d9-a9a0-4ec9-bdd4-730a49b7dc2a"
    ],
    "0119": [
      "0ff25196-66e4-4d8b-bc17-3eaba2bff11b"
    ],
    "0120": [
      "c85e4584-a9c1-4d06-bdc1-7a45239aede1"
    ],
    "0122": [
      "ef224bd9-1471-4498-960d-d1ca7f8a1217"
    ],
    "0123": [
      "776c13a6-59f1-4a0a-a067-4d6028a1fec1"
    ],
    "0124": [
      "54941b2f-d63c-4026-9b2f-49458950f26a"
    ],
    "0126": [
      "0854d58e-e8cf-4f90-a4c8-86b9d52e53c7"
    ],
    "0127": [
      "87e0f8b0-a0b8-4f63-ae87-efd1eb7a22cf"
    ],
    "0129": [
      "f6c545ae-42bf-49da-b266-7de907196721"
    ],
    "0131": [
      "80d95891-0bc8-43b6-9335-b76a9e4382c1"
    ],
    "0132": [
      "c66b0ccc-edb4-4eb4-8c93-7cf7f96f8ad3"
    ],
    "0133": [
      "d59acab3-c60c-427d-b65a-9891de84678f"
    ],
    "0134": [
      "aa8c97cd-e98b-4d7c-8972-4065f06efd0f"
    ],
    "0135": [
      "7d246471-51b8-44ef-b666-e201c95fe1f1"
    ],
    "0137": [
      "36c590df-c5d8-4ffd-92e0-e193e31066e2"
    ],
    "0138": [
      "06b859bd-939f-467d-9690-c8ae2dae37f4"
    ],
    "0139": [
      "c4813c0e-fdf3-4ac1-9479-b68ba336e055"
    ],
    "0140": [
      "d5753497-a63a-4b1b-a70a-5d132fb7d2a6"
    ],
    "0141": [
      "da4e7065-ae9f-43a4-98ff-558f3c061b6b"
    ],
    "0142": [
      "f63bf645-bec6-4a84-a1b8-557377215fb0"
    ],
    "0143": [
      "40bcdcfa-1bfc-429b-8661-854a495f0da4"
    ],
    "0145": [
      "f24230b9-f152-4851-b5f3-8b5c35553a93"
    ],
    "0146": [
      "406d4faa-5bc8-496e-97e6-3294a80af719"
    ],
    "0148": [
      "d004d1b9-4910-4955-b0ed-fae90daa1c2b"
    ],
    "0150": [
      "fdedf840-25f9-42b8-a57f-129b357bccd1"
    ],
    "0151": [
      "fd902373-80ab-46bf-9488-4b165ed33ccf"
    ],
    "0152": [
      "bde70d18-a658-4dac-a63d-197bcb9f6691"
    ],
    "0153": [
      "0909581d-a476-4d99-85f5-a79b4e99d7f5"
    ]
  },
  "node_count": 154,
  "generation_model": "deepseek-v3.2",
  "generated_at": "2026-02-10T03:59:24.857102",
  "article_count": 124,
  "generation_time_s": 96.62374687194824
}